Related Experiment Video
Updated: May 22, 2026
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylation
Rodney B Luwor1, Xiaowen Chin, Andrew B McGeachie
1Department of Surgery (RMH/WH), University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Growth Factors (Chur, Switzerland)
|May 12, 2012
Summary
Endocytosis regulates epidermal growth factor receptor (EGFR) signaling. Inhibiting dynamin II (Dyn II) reduced Stat3 activation but not Erk1/2, suggesting spatial control of EGFR signaling impacts tumor cell activity.
Area of Science:
- Cell biology
- Molecular signaling
- Cancer research
Background:
- Receptor tyrosine kinases (RTKs) initiate signaling cascades upon ligand binding.
- Endocytosis was thought to inactivate signaling by receptor degradation.
- Emerging evidence highlights endocytosis's role in initiating and sustaining signaling.
Purpose of the Study:
- To investigate the role of endocytosis in epidermal growth factor receptor (EGFR) signal attenuation and differential signaling.
- To determine how dynamin II (Dyn II) inhibition affects downstream signaling pathways.
- To explore the implications for therapeutic targeting in cancer.
Main Methods:
- Inhibition of dynamin II (Dyn II) using a small molecular weight inhibitor.
- Utilized Dyn II siRNA and shRNA for gene silencing.
- Assessed EGF-mediated phosphorylation of EGFR, Stat3, and Erk1/2.
- Measured Stat3 transcriptional reporter activity and nuclear accumulation.
Main Results:
- Dyn II inhibition reduced EGF-mediated Stat3 phosphorylation and transcriptional activity.
- Dyn II inhibition minimally affected EGF-mediated EGFR and Erk1/2 phosphorylation.
- Dyn II inhibition did not alter EGFR/Stat3 association.
- Dyn II siRNA reduced Stat3 nuclear accumulation.
Conclusions:
- Endocytosis, regulated by Dyn II, differentially controls EGFR signaling pathways.
- Spatial and temporal regulation of EGFR by endocytosis influences Stat3 and Erk1/2 activation.
- These findings have implications for targeted cancer therapies involving endocytosis and signaling inhibitors.
Related Concept Videos
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:12What are Second Messengers?
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...